BSD Home Page
Search:

Breaking News

9/12/2008
The U.S. Food and Drug Administration (FDA) grants 510(k) clearance to market BSD Medical’s MicroThermX-100 Microwave Ablation System. Click to see an Image

 
Hyperthermia Cancer Treatment and Therapy Systems

BSD Medical Corporation (NASDAQ: BSDM) develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy as provided by focused radio frequency and microwave energy. BSD Medical is also making major progress in the application of its technology for other therapies.


Dr. Sennewald Medizintechnik GmbH. is BSD Medical's European Distributor. Click here to go to the Dr. Sennewald Medizintechnik GmbH website.



11/14/2008: BSD Medical Corp. Reviews Groundwork for MicroThermX-100 Sales Launch
11/14/2008: BSD Medical Files Year End (10-K) Report—Sales Up 81% over Prior Year
11/05/2008: BSD Medical: Preoperative Hyperthermia Therapy Combined with Systemic Chemotherapy ‘Boosts’ Results in Treating Soft Tissue Sarcoma
10/29/2008: Hyperthermia Therapy Used to Activate a Gene Delivery System for Tumors
10/27/2008: BSD Medical Supports National Breast Cancer Awareness Month in Dual Role
10/23/2008: European Journal of Cancer Emphasizes ‘Coming of Age’ for Deep Hyperthermia
10/14/2008: Dr. Michael Nobel Delivers Keynote Address on Hyperthermia Therapy at Japanese Cancer Symposium
10/08/2008: BSD Medical to Present Its Systems at China Medical Equipment Fair, Asia’s Largest Medical Device Event
10/06/2008: Hyperthermia Therapy for Cancer a Key Topic of Discussion at ESTRO Symposia in Goteborg, Sweden
10/01/2008: BSD Medical Participates in ASTRO, SROA and RRS Conferences
More Press Releases

If you know someone who would benefit from knowing about BSD Medical and its products please click here to send them an email directing them to this site.
BSD Medical 2188 West 2200 South Salt Lake City, UT 84119-1326 Phone: 801-972-5555 Fax: 801-972-5930 Email Us
Terms of Use | Privacy Policy
Copyright © 2005 BSD Medical Corporation. All rights reserved.